JPRN-UMIN000002844已完成2 期
Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex - Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex
Department of Dermatology Graduate School of Medicine, Osaka University0 个研究点目标入组 21 人开始时间: 2009年12月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with severe mental retardation who cannot carry out this treatment plan. 2) Patients with a past history of hypersensitivity to macrolide antibiotics. 3) Patients who were judged unsuitable for this study by the investigator.
研究者
相似试验
招募中
2 期
Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1neurofibromatosis type1JPRN-UMIN000015081Department of Dermatology Graduate School of Medicine, Osaka University3
招募中
2 期
Clinical trial for development of topical rapamycin treatment for rosacearosaceaJPRN-UMIN000008315Department of Dermatology Graduate School of Medicine, Osaka University5
招募中
2 期
Clinical trial for development of topical rapamycin treatment for white macules due to tuberous sclerosis complex, vitiligo vulgaris, and other congenital diseasestuberous sclerosis complex, vitiligo vulgaris, white macules due to congenital diseasesJPRN-UMIN000006108Department of Dermatology Graduate School of Medicine, Osaka University21
进行中（未招募）
不适用
Topical rapamycin to treat fibrofolliculomas in Birt-Hogg-Dubé syndrome.Facial fibrofolliculomas in Birt-Hogg-Dubé syndromeEUCTR2009-012740-17-NLMUMC20
已完成
3 期
Topical rapamycin to treat fibrofolliculomas in Birt-Hogg-Dubé syndromefibrofolliculomashair follicle tumors1008362410040798NL-OMON35713niversiteit Maastricht20